Author Affiliations1Research Institute of Internal and Preventive Medicine, 630089, Novosibirsk, Boris Bogatkov str., 175/1
2Institute of Internal and Preventive Medicine 630089, Novosibirsk, Boris Bogatkov str., 175/1
3Institute of Internal and Preventive Medicine 630089, Novosibirsk, Boris Bogatkov str., 175/1
4Institute of Internal and Preventive Medicine 630089, Novosibirsk, Boris Bogatkov str., 175/1
5Institute of Internal and Preventive Medicine, 630089, Novosibirsk, Boris Bogatkov str., 175/1
Borron P., McIntosh J.C., Korfhagen T.R. et al. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo // Am. J. Physiol. Lung Cell. Mol. Physiol. 2000. 278. (4). L840-L847.
Chuchalin A.G., Pneumonia: the actual problem in medicine of the XXI century // Terapevticheskiy arkhiv = Therapeutic archive. 2016. 88. (3). 4-12. [In Russian].
Chuchalin A.G., Sinopalnikov A.I., Strachunskiy L.S. et al. Community-acquired pneumonia in adults: practical recommendations for diagnosis, treatment and prevention // Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical microbiology and antimicrobial chemotherapy. 2006. 8. (1). 54-86. [In Russian].
Eisner M.D., Parsons P., Matthay M.A. et al. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury // Thorax. 2003. 58. (11). 983-988.
Fernandez E., Krueger P., Loeb M. Predictors of health decline in older adults with pneumonia: findings from the Community-Acquired Pneumonia Impact Study // BMC Geriatr. 2010. 10. (1). 1-21.
Gardai S.J., Xiao Y.-Q., Dickinson M. et al. By binding SIRP-alpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation // Cell. 2003. 115. (1). 13-23.
Hickman-Davis J.M., O’Reilly P., Davis I.C. et al. Killing of Klebsiella pneumoniae by human alveolar macrophages // Am. J. Physiol. Lung Cell. Mol. Physiol. 2002. 282. (5). L944-L956.
KovalkovaN.A. Ragino Yu.I., Logvinenko N.I., Merekina E.V., Voevoda M.I. Value of surfactant proteins in the diagnosis of therapeutic diseases // Terapevticheskiy arkhiv = Therapeutic archive. 2015. 87. (1). 115-119. [In Russian].
Kremlev S.G., Phelps D.S. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production // Am. J. Physiol. Lung Cell. Mol. Physiol. 1994. 267. (6, Pt. 1). L712-L719.
Mikerov A.N. The role of surfactant protein A in immune defense of the lungs // Fundamental'nye issledovaniya = Fundamental research. 2012. (2). 204-207. [In Russian].
Mikerov A.N., Umstead T.M., Huang W. et al. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages // Am. J. Physiol. Lung Cell. Mol. Physiol. 2005. 288. (1). L150-L158.
Phelps D.S. Surfactant regulation of host defense function in the lung: a question of balance // Pediatr Pathol. Mol. Med. 2001. 20. (4). 269-292.
Schagat T.L., Wofford J.A., Wright J.R. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils // J. Immunol. 2001. 166. (4). 2727-2733.
Wright J.R., Youmans D.C. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage // Am. J. Physiol. Lung Cell. Mol. Physiol. 1993. 264. (4, Pt. 1). L338-L344.
Wu H., Kuzmenko A., Wan S. et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability // J. Clin. Invest. 2003. 111. (10). 1589-1602.
Wunderink R.G., Mutlu G.M. Pneumonia // Encyclopedia of respiratory medicine. Eds. G.J. Laurent, S.D. Shapiro. Oxford: Elsevier, 2006. 402-407.
